Perioperative high-dose nicotine patch for pain sensitivity in male smokers undergoing thoracic surgery
Official title: Effect of Perioperative High-dose Transdermal Nicotine Patch on Pain Sensitivity Among Male Abstinent Tobacco Smokers Undergoing Thoracic Surgery: A Randomized Controlled Pilot Study
Run by Henan Provincial People's Hospital · NCT07250230 · Data updated 2026-11-12
We will try a high-dose nicotine patch around the time of surgery to see if it reduces pain sensitivity in adult male smokers having thoracoscopic lung surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | Men only |
| Enrollment | 80 (estimated) |
| Sponsor | Henan Provincial People's Hospital Academic / other |
| Locations | 1 site (Zhengzhou, Henan) |
| Status | Recruiting |
| Started | November 30, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | January 22, 2026 |
| Trial ID | NCT07250230 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are men 18–75 who are regular smokers (≥2 years, >10 cigarettes/day in the past 6 months or FTND ≥2), scheduled for thoracoscopic lobectomy/segmental/wedge resection, with BMI 18–28 kg/m2 and ASA I–III.
✕Probably not a fit
Women, non-smokers, and patients with severe cardiovascular/cerebrovascular or psychiatric disease, alcohol dependence, long-term sedative or analgesic use, or those not undergoing thoracic surgery are unlikely to benefit or may be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled pilot compares perioperative high-dose transdermal nicotine patch to usual care or placebo in adult male smokers undergoing thoracoscopic lobectomy, segmental, or wedge resection. Eligible participants are men aged 18–75 with a regular smoking history and ASA physical status I–III who consent to perioperative nicotine replacement. The trial collects perioperative pain sensitivity measures, postoperative pain scores, and analgesic consumption to gauge preliminary effects. Results will inform feasibility and the design of larger trials.
Why it matters
Potential benefit: If successful, perioperative nicotine replacement could reduce postoperative pain sensitivity and lower opioid requirements for male smokers after thoracic surgery.
How similar studies have gone: Prior work supports nicotine replacement for withdrawal and suggests possible analgesic effects, but the specific use of perioperative high-dose transdermal nicotine in thoracic surgery is novel and evidence is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male, aged 18-75 years, with a body mass index (BMI) of 18-28 kg/m2 Between; 2. Thoracoscopic lobectomy/segmental/wedge resection under general anesthesia; 3. American Society of Anesthesiologists (ASA) classifications I-III Level; 4. Regular smoking for more than 2 years, smoking more than 10 cigarettes per day in the past 6 months, and not successfully quitting smoking within 1 month (after admission, the doctor and nurse informed the smoking cessation plan to intervene before starting to stop smoking or 1 ≤ cigarette count ≤ 10 cigarettes/day in the past month), FTND score ≥ 2; 5. No severe respiratory diseases, no serious cardiovascular and cerebrovascular diseases (hypertension is treated with SBP ≤ 160mmHg, DBP ≤ 90mmHg after systemic treatment); 6. Obtain informed consent. Exclusion Criteria: 1. Those who have a history of alcoholism, long-term use of sedatives or analgesics; 2. Patients with psychiatric and nervous system diseases (such as Parkinson's, depression, schizophrenia) and severe audio-visual dysfunction before surgery; 3. Preoperative systolic blood pressure \> 180mmHg or diastolic blood pressure \> 110mmHg; 4. Patients who were converted to thoracotomy during thoracoscopic surgery 5. Patients who are transferred to the intensive care unit after surgery; 6. Patients who refuse to use analgesic pump treatment/do not configure the analgesic pump according to regulations; 7. Patients who have self-removed patches/short hospital stay resulting in a postoperative observation time of \< 48 hours
Where it's running
-
Department of Anaesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan
Zhengzhou, Henan, China Recruiting
Study contacts
- Study coordinator: Wei Li
- Email: 1131691709@qq.com
- Phone: +8619838263779
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Anterior Knee Nerves Block vs Femoral Nerve Block for Knee Arthroscopy
This trial tests whether an anterior nerves of the knee (ANK) block provides similar pain relief to a femoral nerve block after knee arthroscopy in adults, aiming to reduce quadriceps weakness.
-
Esmolol vs Dexmedetomidine for opioid-sparing in laparoscopic gynecologic surgery
This study tests whether low-dose esmolol or dexmedetomidine, given during surgery, reduces opioid use and improves pain control after laparoscopic hysterectomy compared with placebo.
-
Three nerve blocks for knee replacement: which one works best
This trial tests three different nerve blocks used during knee replacement to see which provides the best pain relief for patients after surgery.
-
Rectointercostal plane block to reduce pain after laparoscopic gallbladder removal
This study tests whether giving a rectointercostal block during laparoscopic cholecystectomy can lower postoperative pain for patients without changing general anesthesia.
-
How people puff IQOS Iluma i vs IQOS 2.4 and how flavors feel
This study tests how exclusive IQOS users puff the newer Iluma i versus the older 2.4, and whether preferred flavor affects puffing and sensory experience.
-
Do a single nicotine pouch affect cigarette craving and brain response to smoking cues
This study tests whether a single 6 mg oral nicotine pouch can reduce craving and alter prefrontal brain responses to smoking cues in adults who smoke cigarettes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.